Orchid Island Capital, Inc. Liquidation Value
Cash & Equivalents
Key Metrics
Cash Liquidation Value
- Current Liabilities: not reported in this period (annual-only)
- Finance Lease Liability: not reported
- Long-Term Debt: not reported
- Operating Lease Liability: not reported
Liquid Liquidation Value
- Current Liabilities: not reported in this period (annual-only)
- Accounts Receivable: not reported
- Finance Lease Liability: not reported
- Long-Term Debt: not reported
- Operating Lease Liability: not reported
Operating Liquidation Value
- Current Liabilities: not reported in this period (annual-only)
- Accounts Receivable: not reported
- Finance Lease Liability: not reported
- Inventory: not reported
- Long-Term Debt: not reported
- Operating Lease Liability: not reported
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $674.02M | $3.43 |
| Liquid Liquidation Value | $674.02M | $3.43 |
| Operating Liquidation Value | $674.02M | $3.43 |
Key Components (as of 2026-03-31)
| Cash & Equivalents | $674.02M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities (total reported; current not separately disclosed) | $11.28B |
| Long-term Debt (?) | N/A |
| Op. Lease Liability (?) | N/A |
| Finance Lease (?) | N/A |
| Shares Outstanding | 196.7M |
Explore all 90 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $674.02M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2025-12-31 | $665.87M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2025-09-30 | $583.89M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2025-06-30 | $440.76M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2025-03-31 | $396.39M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-12-31 | $309.33M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-09-30 | $322.11M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-06-30 | $241.04M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SEC Filings
| Period | Form | Filed | Link |
|---|---|---|---|
| 2026-03-31 | 10-Q | 2026-04-24 | View |
| 2025-12-31 | 10-K | 2026-02-20 | View |
| 2025-09-30 | 10-Q | 2025-10-24 | View |
| 2025-06-30 | 10-Q | 2025-07-25 | View |
| 2025-03-31 | 10-Q | 2025-04-25 | View |
| 2024-12-31 | 10-K | 2025-02-21 | View |
| 2024-09-30 | 10-Q | 2024-10-25 | View |
| 2024-06-30 | 10-Q | 2024-07-26 | View |
AI Insights
Orchid Island Capital (ORC) is an externally managed Agency RMBS REIT with a balance sheet structured around a single highly-leveraged asset class. As of March 31, 2026, total assets were $12.67B against total liabilities of $11.28B, yielding reported stockholders' equity of $1.39B. Under a liquidation lens, the recovery picture is broadly positive relative to book but carries material execution risk given scale and leverage.
The primary asset is $11.34B of Agency RMBS (Fannie Mae/Freddie Mac pass-throughs) carried at fair value under the fair value option. Agency RMBS is the closest analog to cash in the fixed-income universe—these are government-guaranteed instruments with active secondary markets. Under a fire-sale liquidation scenario, a haircut of 1-3% on $11.34B is realistic given the 4.1% weighted-average repo haircut already in place and the portfolio's effective duration of 3.0 (implying meaningful price sensitivity to rate moves). The filing also discloses that a +200bps rate shock would reduce portfolio market value by approximately 3.34%, which bounds the plausible discount range on a distressed unwind. Unrestricted cash was $674M (100% recovery) and restricted cash (repo margin pledged to counterparties) was $86M.
The dominant liability is $10.86B in repurchase agreements, which must be settled at face value on wind-up. Remaining maturity is 2-227 days (weighted average 46 days), meaning essentially all repo debt would need to be settled or rolled within the wind-up period—a material execution constraint. At face value liabilities of $11.28B versus a conservative 98% haircut on RMBS ($11.11B recovered) plus $760M cash, gross recoverable assets approximate $11.87B against $11.28B of liabilities, yielding a thin positive recovery buffer of roughly $590M before transaction costs, hedging unwind losses, and management termination fees (equal to 3x trailing annual management fees, approximately $48M based on Q1 2026 annualized run-rate of $16M). The TBA net long position of $95M notional adds incremental exposure that would need physical delivery or cash settlement.
Compared to December 31, 2025, the RMBS portfolio grew by $710M (from $10.63B to $11.34B), repurchase agreement obligations increased by $749M (from $10.12B to $10.86B), and equity grew modestly from $1.37B to $1.39B, funded largely by $107.8M in ATM equity issuance. Economic leverage ticked up from 7.3x to 7.9x. The portfolio's effective duration extended from 2.513 to 3.005, increasing mark-to-market sensitivity. Three-month CPR accelerated to 14.7% from 15.7% at year-end but remains elevated relative to the 7.8% pace a year ago—prepayment acceleration reduces premium amortization drag but also shrinks the collateral base. The filing discusses a war in Iran commencing February 28, 2026 as creating market dislocation and elevated interest rate volatility; no specific credit loss or mark-down event on the RMBS portfolio is disclosed. The management termination fee contingency is discussed in MD&A but is not separately XBRL-tagged.
▼ Community Notes